Global Health News and Research

RSS

Unexpected discovery could improve detection of malaria infections

While the global health community has made great strides toward eradicating malaria through prevention and treatment strategies, rapid and inexpensive methods to diagnose submicroscopic malaria in individuals who have no clinical symptoms and undetectable levels of disease-causing parasites in their blood remain an unmet need.

4 May 2018

Osteoporosis drug prevents spread of basal-like breast cancer in mice

Researchers in China have discovered that an enzyme called UGT8 drives the progression of basal-like breast cancer, an aggressive form of the disease that is largely untreatable.

4 May 2018

New Digital GP Service from Aviva and Now Healthcare

Aviva is giving large corporate health insurance customers swift, convenient access to more than 1,000 GPs, through a new collaboration with digital health company, Now Healthcare Group (NHG).

From Infohealth Ltd 1 May 2018

The Impact of Air Pollution on Childhood Asthma

It is a well-established fact that air pollution in towns and cities affects our health. Dr Haneen Khreis discusses the latest research into the effect of air pollution on childhood asthma, and the steps that transport policy makers can take to reduce the prevalence of the condition.

1 May 2018

Parkinson's disease pivotal trial treats first patient using focused ultrasound

The first patient in a multicenter pivotal trial using focused ultrasound to address the major motor symptoms of Parkinson's disease has been treated at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center in New York.

27 Apr 2018

Blue light exposure at night linked to higher risk of developing breast and prostate cancer

A study performed by an international team led by the Barcelona Institute for Global Health (ISGlobal), a center supported by the "la Caixa" Foundation, reports a link between exposure to blue light at night and higher risk of developing breast and prostate cancer.

25 Apr 2018

Why are Antibiotics Overprescribed for Meningitis Treatment?

Meningitis is a relatively rare disease, with our estimates for the incidence of meningitis in the UK being about 3.2 cases of meningitis per 100,000 adults. Crucially, bacterial meningitis is linked to significant morbidity and mortality - up to 30% mortality in pneumococcal meningitis cases.

25 Apr 2018

Researchers gain ground-breaking insights into how inflammatory diseases work

A research team from Queen's University Belfast, in collaboration with an international team of experts, have made ground-breaking insights into how inflammatory diseases work.

25 Apr 2018

Elevated immune function during childhood linked to stunted growth

Elevated immune function during childhood results in as much as 49 percent growth reduction in Ecuador's indigenous Shuar population, researchers reported in the Proceedings of the National Academy of Sciences.

24 Apr 2018

Researchers design creative new approach to regenerate injured hearts

Heart disease is a major global health problem--myocardial infarction annually affects more than one million people in the U.S. alone, and there is still no effective treatment.

24 Apr 2018

Study: Young children should be priority for snail fever treatment

Infants in some of the world's poorest regions are vulnerable to a common worm parasite infection and their treatment should become a priority, according to a study.

17 Apr 2018

Research reveals new mechanism by which HIV evades the immune system

Scientists have just discovered a new mechanism by which HIV evades the immune system, and which shows precisely how the virus avoids elimination. The new research shows that HIV targets and disables a pathway involving a number of biological molecules that are key in blocking viral activity and clearing infection.

17 Apr 2018

Artificial antimicrobial peptides may help fight against drug-resistant bacteria

During the past several years, many strains of bacteria have become resistant to existing antibiotics, and very few new drugs have been added to the antibiotic arsenal.

16 Apr 2018

Medical device coated with new bacteria resistant materials approved for use by hospitals

A medical device coated with new bacteria resistant materials, discovered by a team at the University of Nottingham, has been approved for use by hospitals in the UK and Europe.

13 Apr 2018

Deep learning enhances smartphone microscopes into laboratory-grade equipments

Researchers at the UCLA Samueli School of Engineering have demonstrated that deep learning, a powerful form of artificial intelligence, can discern and enhance microscopic details in photos taken by smartphones. The technique improves the resolution and color details of smartphone images so much that they approach the quality of images from laboratory-grade microscopes.

13 Apr 2018

Simple web-based tool for evidence-based integration of disease control

It's a simple idea: Pair the control of a neglected tropical disease with a more prominent disease that afflict the same populations to reduce morbidity and mortality. The approach could be a win-win, but for public health officials, having evidence to support implementation of an integrated approach is vital.

12 Apr 2018

Short international trips can lead to spread of colistin resistance

The emergence of antibiotic resistance among dangerous pathogens is increasingly problematic worldwide. Many strains of infectious bacteria have become multidrug-resistant, and cannot be treated with common antibiotic therapies.

11 Apr 2018

Nosopharm and UIC reveal pharmacology of new class of antibiotics to combat drug resistance

Nosopharm, a company dedicated to the research and development of new anti-infective drugs, and the University of Illinois at Chicago today announce the publication of a study in Molecular Cell on the mechanism of action of odilorhabdins, a new class of antibiotics to combat antibiotic resistance.

9 Apr 2018

Research team identifies new class of antibiotics to fight drug resistance

Researchers from the University of Illinois at Chicago and Nosopharm, a biotechnology company based in Lyon, France, are part of an international team reporting on the discovery of a new class of antibiotics.

6 Apr 2018